Last reviewed · How we verify
NCT06987032: HORUZ
Hemodynamics in Chronic Kidney Disease
trial in Chronic Kidney Failure in 71 participants. Completed in 9 March 2022.
9 March 2022
Quick facts
| Lead sponsor | Ziekenhuis Oost-Limburg |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 71 |
| Start date | 9 January 2021 |
| Primary completion | 9 March 2022 |
| Estimated completion | 9 March 2022 |
| Sites | 1 location across Belgium |
Conditions studied
- Chronic Kidney Failure — all drugs for Chronic Kidney Failure →
Sponsor
Ziekenhuis Oost-Limburg — full company profile →
Who can join
18 and older, any sex, with Chronic Kidney Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to learn about the role of thoracic and whole body bioimpedance in the hemodynamic profile of patients with chronic kidney disease. The main question it aims to answer is: \- Is bioimpedance-determined fluid status associated with kidney function decline in patients with chronic kidney disease stage 3 - 5 (non dialysis).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06987032
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Kidney Failure
Currently open trials in the same condition.
- NCT07348237 — A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) · Phase 1 · recruiting
- NCT06981585 — Physical Impairments in Children With Chronic Renal Failure · recruiting
- NCT06660160 — Group Exercise Program Supported By Audiovisual Media During Hemodialysis · NA · active not recruiting
- NCT05562869 — Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction · Phase 3 · recruiting
- NCT05445219 — Identifying Therapeutic Hemodialysis Targets Through Cerebrovascular Reactivity; RESPIRACT 2 · active not recruiting
Other Ziekenhuis Oost-Limburg trials
Trials by the same sponsor.
- NCT07281534 — Test-Retest Reliability of Cardiopulmonary Exercise Testing With Echocardiography · NA · recruiting
- NCT07123818 — AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening · NA · active not recruiting
- NCT06994091 — Imaging Comparison for the Preoperative Planning and Diagnosis of DIE: a Multicenter Retrospective Study. · not yet recruiting
- NCT06185608 — The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks · NA · recruiting
- NCT06810479 — A Study Comparing Two Mandibular Advancement Devices in the Treatment of Sleep Apnea · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06987032 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ziekenhuis Oost-Limburg
- Last refreshed: 23 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06987032.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing